Piper Jaffray downgraded Inovio Pharmaceuticals (NASDAQ: INO) from Overweight to Neutral with a price target of $9.00 (from $13.00).Analyst Dr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE